Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Clinical trial NCT03274661 · COMPLETED
Trial details
- NCT number
- NCT03274661
- Sponsor
- Baptist Health South Florida
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2020-10-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.